Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model. - Hanada K; Fukasawa K; Hinata H; Imai S; Takayama K; Hirai H; Ohfusa R; Hayashi Y; Itoh F (Cancer science, 2022)